The essential Golgi protein Sly1 is a member of the SM (Sec1/mammalian Unc-18) family of SNARE chaperones. Sly1 was originally identified through gain-of-function alleles that bypass requirements for diverse vesicle tethering factors. Employing genetic analyses and chemically defined reconstitutions of ER-Golgi fusion, we discovered that a loop conserved among Sly1 5 family members is not only autoinhibitory, but also acts as a positive effector. An amphipathic helix within the loop directly binds high-curvature membranes; membrane binding is required for relief of Sly1 autoinhibition and allows Sly1 to directly tether incoming vesicles to the Qa-SNARE on the target organelle. The SLY1-20 allele bypasses requirements for diverse tethering factors but loses this functionality if Sly1 membrane binding is impaired. We propose that 10 long-range tethers, including Golgins and multisubunit tethering complexes, hand off vesicles to Sly1, which then tethers at close range to activate SNARE assembly and fusion in the early secretory pathway. 25 2010; Rizo and Sudhof, 2012; Sudhof and Rothman, 2009) but biochemical work, structural studies, and single-molecule force spectroscopy suggest that SM proteins are assembly chaperones for trans-SNARE complex formation, and that SMs act, at least in part, by templating the initial SNARE zippering reaction (Baker et al., 2015; Jiao et al., 2018) and by protecting appropriately formed prefusion complexes from kinetic proofreading by the SNARE 30
INTRODUCTION 15
Traffic through the secretory and endocytic systems depends on accurate and timely targeting of transport vesicles to acceptor organelles. The terminal stage of targeting is membrane fusion, catalyzed by the formation of trans-SNARE complexes that zipper together, doing the mechanical work of moving two membranes into proximity and driving their merger. Although SNAREs alone can drive fusion and confer some compartmental selectivity, 20 spontaneous SNARE assembly is slow and error-prone. Consequently, an array of tethering factors and SNARE chaperones are indispensable in vivo (Baker and Hughson, 2016; Gillingham and Munro, 2019) . For example, every SNARE-mediated fusion event that has been closely examined requires a cofactor of the Sec1/mammalian Unc-18 (SM) family.
For decades the mechanisms of SM protein function were enigmatic (Carr and Rizo, Fig. 1 . New gain-of-function SLY1 alleles. A. Selection used in this study. A library of SLY1* alleles was constructed by PCR-based mutagenesis and cloned into a single-copy plasmid. The library was then transformed into a SLY1 uso1∆ strain, with USO1 provided on a balancer plasmid bearing the counterselectable URA3 marker. Ejection of pUSO1 was forced by 5-fluoroorotic acid . This positively selects viable cells carrying dominant mutant SLY1* alleles that bypass the otherwise essential USO1 requirement. B. Locations within Sly1 (PDB: 1MQS) of single missense substitutions that suppress requirements for Ypt1, or for both Ypt1 and Uso1. The loop is indicated in purple, with the dashed line denoting the portion of the loop not resolved in the structure. Yellow shading indicates the domain 3a helical hairpin which, by analogy to Vps33 and Munc18-1, is hypothesized to scaffold assembly of Qa-and R-SNARE trans-complexes.
loop, but non-adjacent within the linear polypeptide sequence. One of these was T559I. A genomic survey for gene pairs exhibiting spontaneous suppressing interactions found that a substitution at the same position, T559K, dominantly suppressed deficiencies of both the GARP subunit Vps53 and the Arf GAP Glo3 (van Leeuwen et al., 2016) . Most of the gain-offunction single substitutions that we tested suppressed ypt1-3 but, in contrast to the multi-95 site mutants obtained in the initial selection for uso1∆ bypass, were unable to suppress uso1∆.
( Supplementary Fig. S1; Supplementary Table 1 ). Thus, strong Sly1 gain-of-function phenotypes can arise through individual substitutions or through the compounded effects of multiple weak driver substitutions. These results show that earlier screens were not, as had been suggested, saturated (Li et al., 2007) . 100 As noted by Baker and coworkers (2015) , helices α20 and α21 sit atop two conserved regions that in Vps33 are of special importance for SNARE binding: domain 3a, which serves as a scaffold to nucleate the parallel, in-register assembly of the Qa-and R-SNAREs, and an aromatic pocket that serves as a high-affinity anchoring point for the R-SNARE juxtamembrane linker. On the basis of the Vps33 structures and the original SLY1-20 and SLY1-105 15 alleles, Baker et al. (2015) speculated that when closed, the Sly1 loop might prevent R-SNARE binding to Sly1. The dominant suppressors obtained in our screen and data presented below reinforce and extend that model. 110 In vivo genetic tests and crude in vitro transport systems (Baker et al., 1988; Ballew et al., 2005; Ruohola et al., 1988 ) cannot tell us whether Sly1* mutants must interact with additional proteins beyond the core SNARE fusion machinery to manifest gain of function. To overcome this limitation, we developed a chemically defined reconstituted proteoliposome (RPL) system to monitor fusion driven by ER-Golgi SNAREs ( Fig. 2A) . This system, adapted from an 115 assay developed to study homotypic vacuole fusion (Zucchi and Zick, 2011) , employs two orthogonal pairs of Förster resonance energy transfer (FRET) probes, to simultaneously monitor both lipid and content mixing in small (20 µL) reaction volumes. Although we present only content mixing data in this manuscript, the lipid mixing signal provides an intrinsic control, allowing us to detect partial hemifuison or fusion that is accompanied by lysis. mixing readout. C, Requirement for Sly1. Reactions were set up with Q-and R-SNARE RPLs, and 3% PEG. Fusion activity was monitored for 5 min., and then Sly1 was added at time = 0 (arrows) to the indicated final concentrations. Note that fusion activity is saturated at 100 nM [Sly1] . D. Requirement for tethering. Reactions were set up with Q-and R-SNARE RPLs, with the indicated final concentrations of PEG. Fusion activity was monitored for 5 min., and then Sly1 was added to a final concentration of 250 130 nM. Note that at 6% and 7% PEG, some Sly1-independent fusion occurs prior Sly1 addition. E. Effects of the SNARE disassembly machinery. Reactions were set up with Q-and R-SNARE RPLs, and with or without PEG, Sec17, Sec18, ATP, and Sly1, as indicated. Fusion was initiated by adding Sly1. For C-E, points show mean ± s.e.m. of three independent experiments; in many cases the error bars are smaller than the symbols. Gray lines show least-squares nonlinear fits of a second-order kinetic model.
Sly1 bypass suppressors are hyperactive in a minimal fusion system

135
In previous work SMs were shown to stimulate SNARE-mediated lipid mixing, but only in the presence of tethering factors or molecular crowding agents that substitute for tethering factors (Furukawa and Mima, 2014; Yu et al., 2015) . Consistent with these previous studies, content mixing in heterotypic reactions between RPLs bearing the R-SNARE Sec22, and RPLs bearing the Q-SNAREs Sed5, Bos1 and Bet1, was strongly stimulated only when both Sly1 and 140 a crowding agent (polyethylene glycol 6000; PEG) were provided (Fig. 2C,D) . Under these experimental conditions the stimulatory effect of Sly1 saturated at 100 nM. Two other studies have reported in vitro stimulation of fusion by Sly1, though at a 45× higher concentration of Sly1 than the 100 nM used in most of our experiments (Furukawa and Mima, 2014; Jun and Wickner, 2019) . Pre-incubation of the RPLs with Mg 2+ ·ATP and the SNARE disassembly 145 chaperones Sec17 and Sec18 (yeast α-SNAP and NSF) resulted in immediate and almost complete fusion upon Sly1 addition ( Fig. 2E) , likely indicating that SNAREs on the RPLs equilibrate between productive and refractory configurations, and that Sec17/18-mediated disassembly shifts this equilibrium toward productive, Sly1-reactive configurations.
Next, we compared the activity of wild type Sly1 to three bypass suppressors: Sly1-20 150 and two of the new alleles identified in our screen. Each variant was tested in reactions containing 3% or 0% polyethylene glycol-6000 (PEG). At 3% PEG all four Sly1 variants drove fusion with similar efficiency (Fig. 3A) . In marked contrast, at 0% PEG ( Fig. 3B ) all three Sly1 suppressor mutants drove fusion substantially more efficiently than the wild type. In reactions containing Sec17, Sec18, and Mg 2+ ·ATP (Fig. 3C,D) the same overall pattern emerged. As PEG 155 bypasses requirements for tethering factors and potentiates SM-mediated fusion, our results show for the first time that these Sly1 gain-of-function mutants are intrinsically hyperactive, requiring only SNAREs (or SNAREs and disassembly chaperones) to stimulate fusion, and not additional cellular factors such as Rabs or tethering factors. These results directly mirror the in vivo genetic suppression patterns observed for SLY1-20 and otherwise essential vesicle 160 tethering regulators and effectors. Fig. 2 , with the initial mixture containing R-SNARE and Qabc-SNARE RPLs and, as indicated for each row of panels, 0 or 3% PEG, and in the absence or presence of Sec17, Sec18 (both 100 nM), and 165 ATP (1 mM). After a 5 min incubation, wild type Sly1 or the indicated mutants were added (arrows) at 0, 25, 100, or 400 nM to initiate fusion. Points show the mean ± s.e.m. from three or more independent experiments; in many cases the error bars are smaller than the symbols. Gray lines show least-squares nonlinear fits of a second-order kinetic model.
The Sly1 regulatory loop has positive as well as negative functions
If the Sly1 loop is autoinhibitory, we might predict that excision of the entire loop should hyperactivate Sly1 as much as or more than the suppressing mutations characterized above.
To test this hypothesis, we used the ROSETTA software environment (Leaver-Fay et al., 2011) to design a set of Sly1 variants in which the loop is replaced by short peptide linkers ( Fig. 4A; 175 Supplementary Table 2) . Surprisingly, each of the "loopless" sly1 mutants tested in vivo exhibited recessive lethality or slow growth in the presence of the counterselection agent 5-FOA at 30° C; temperature sensitivity; and an inability to bypass deficiencies in YPT1 or USO1.
One mutant, sly1-0_2, exhibited somewhat more robust growth compared to the other alleles when present as the sole copy of SLY1. sly1-0_2 was therefore called sly1∆loop and subjected 180 to further scrutiny.
To gain genome-scale insight into the sly1∆loop allele's loss of function, we used synthetic genome array (SGA) analysis. SGA measures the synthetic sickness or rescue (suppression) of a query allele versus a genome-scale collection of loss-of-function alleles (Tong and Boone, 2005) . sly1∆loop was knocked in at the genomic SLY1 locus. The resulting 185 strain grew normally on rich YPD medium containing 5-FOA at 30° C, but slowly compared to strains with wild-type or hyperactive SLY1 alleles at 37° C (Fig. 4B) . When subjected to SGA analysis, sly1∆loop had a synthetic-sick or synthetic-lethal interaction with ten of twelve genes previously reported to exhibit positive suppressing interactions with SLY1-20, as well as with dozens of additional genes that function in organelle biogenesis and membrane traffic -190 especially traffic into and through the Golgi ( Fig. 4C; Supplementary Dataset 1) . Gene Ontology (GO) analysis (Mi et al., 2019; The Gene Ontology Consortium, 2019) recvealed that enrichment for these gene functions was both selective and statistically significant ( Fig. 4D) .
Wild-type SLY1 activity is also required for resistance to the toxic effects of SEC17 overproduction (Lobingier et al., 2014; Schwartz et al., 2017) , and SEC17 overproduction 195 caused a severe recessive growth defect in sly1∆loop cells ( Fig. 4E) . Overexpressino of a mutant, sec17-FSMS, caused an even more severe growth defect. Together, the genetic and functional genomic results show that sly1∆loop is a recessive loss-of-function allele and not, as expected, a dominant suppressor. Supplementary Table 2 . The domain 3a SNARE assembly template is shown in yellow. B, The sly1∆loop mutant is temperature sensitive for growth. Dilutions of liquid cultures were spotted as 10x serial dilutions onto YPD agar plates and incubated for 2 days at 30° or 37° C. These are knock-ins at the genomic SLY1 locus, in the Y8205 strain background used for SGA analysis. C, Selected SGA results. Genes exhibiting synthetic interactions with sly1∆loop are shown. Scores indicate loge synthetic growth defects (red) or intergenic suppression (blue). A score of -4.6 indicates a 100× synthetic growth defect. Complete SGA results are presented in Supplementary Dataset 1. D, Gene Ontology (GO) Overrepresentation Test of the sly1∆loop SGA dataset. Genes with loge synthetic defect scores ≤ -0.5 were included in the analysis. Bars show all GO-Slim Biological Process categories with statistically significant enrichment scores (*p < 0.05; **p < 10 -2 ; ***p < 10 -6 ). Pvalues were calculated using Fisher's exact test and adjusted for multiple comparisons (Bonferroni's correction; count = 732). Additional details are presented in Supplementary Dataset 1. E SEC17 overproduction is toxic in cells expressing sly1∆loop. sly1∆ mutant cells were maintained with a counterselectable SLY1 balancer plasmid and transformed with single-copy plasmids bearing either SLY1 or sly1∆loop, as well as plasmids carrying SEC17 or sec17-FSMS (Schwartz and Merz, 2009 ). The balancer plasmid was ejected by plating dilutions on media containing 5-FOA and growth was assayed after 2 days of growth at 30° C.
To assess the molecular mechanism of loss-of-function in Sly1∆loop, we returned to the Fig. 3) . Moreover, Sly1∆loop was properly folded as indicated by circular dichroism spectroscopy ( Fig. 5E) . Thus, the fusion defect of Sly1∆loop is not due to a major fraction of misfolded protein, and the sly1∆loop allele is probably not a simple hypomorph. Instead Sly1∆loop is, on a mole-per-mole basis, a less efficient stimulator of SNARE-mediated fusion compared to the wild type. Taken together, the in vivo and in vitro data argue that the Sly1 210 regulatory loop is not only autoinhibitory, but that it also must harbor a positive fusionpromoting activity.
The loop's positive function resides within ALPS-like helix α21
The regulatory loop's most highly conserved region is helix α21 (Fig. 6A, B) . Interestingly, 215 none of the activating gain-of-function mutations isolated to date map to α21. On closer inspection we found that α21 is amphipathic ( Fig. 6C) . We therefore designed a mutant, Sly1-pα21, in which helix α21 is mutated to render it polar rather than amphipathic. Unexpectedly, the sly1-pα21 allele caused recessive extremely slow growth or lethality (Fig. 6D ) -a phenotype markedly more severe than that conferred by the sly1∆loop allele, which lacks the 220 loop altogether.
Amphipathic helices operate as membrane recognition modules across a wide range of proteins, particularly within the early secretory pathway (Bigay and Antonny, 2012) . This suggests a working model: the amphipathic α21 helix probes for the presence of an incoming vesicle and binds to the vesicle's membrane, pulling the loop away from the R-SNARE binding 225 site. This disinhibits Sly1, allowing Sly1 to catalyze trans-SNARE complex assembly. In this model, the Sly1-pα21 protein is nonfunctional because α21 cannot recognize incoming vesicle membranes -and the loop is therefore locked into its auto-inhibited state. To test this hypothesis, we engineered a compound mutant, SLY1-20-pα21. This allele comprises both the activating Sly1-20 mutation (E532K) in α20, and the five α21-polar substitutions (Fig. 6d) . 230 Remarkably, SLY1-20-pα21 cells exhibited wild type growth ( Fig. 6c) . Unlike SLY1-20, however, SLY1-20-pα21 was unable to suppress the lethality of ypt1-3 or uso1∆ deficiencies ( Supplementary Table 1 ), establishing that the amphipathic character of helix α21 is essential for Sly1-20 hyperactivity in vivo. Fig. 6 . Amphipathic helix α21 is indispensable for normal Sly1 function. A, CONSURF analysis of evolutionary conservation within the Sly1 loop. Helix α21 is the most highly conserved portion of the loop. Locations of gain-of-function mutations, and hydrophobic residues within the loop, are indicated, as are the five substitutions in the Sly1-pα21 mutant. B, Position of helix α21 within Sly1. Note that no gain-of-function mutations within α21 have been identified. The loop is purple; the domain 3a templating domain is yellow. C, Helix α21 and residues immediately upstream have the potential to fold into a strongly amphipathic α-helix. The helical wheel renderings comprise the region underlined in black and were produced using HELIQUEST; hydrophobic moment (µH) is indicated. D, Growth phenotypes of cells carrying sly1-pα21, SLY1-20-pα21, and other alleles were assayed in a sly1∆ strain with a SLY1 balancer plasmid, which is ejected in the presence of 5-FOA. (E-J)RPL fusion with (E-G) Sly1-pα and (H-J) the compound mutant Sly1-20-pα21. For reference, fusion is also plotted for Sly1 and Sly1 ∆loop . Reactions were set up with (E,H) 0% PEG, Sec17 and Sec18 (100 nM each), and ATP (1 mM); (F,I) 3% PEG and no Sec17, Sec18 (100 nM each), or ATP; or (G,J F) 0% PEG, Sec17 and Sec18 (100 nM each), and ATP (1 mM). Fusion was initiated at time = 0 by adding Sly1 or its mutants, at the concentrations indicated in the legends at the right side of the figure. Points show mean ± s.e.m. from three or more independent experiments; in many cases the error bars are smaller than the symbols. Gray lines show least-squares nonlinear fits of a second-order kinetic model.
The in vivo results were closely mirrored in fusion experiments with RPLs ( Fig. 6 E-G) . Under 235 every condition tested, Sly1-pα21 was less efficient at stimulating fusion than Sly1∆loop.
Fusion in the presence of Sly1-pα21 was reduced in the absence or presence of PEG, as well as in the presence or absence of Sec17, Sec18, and ATP. In contrast to Sly1-pα21, the compound mutant Sly1-20-pα21 ( Fig. 6 H-J) exhibited a greater ability to stimulate fusion under each of the tested conditions. Importantly, the behaviors of Sly1∆loop and the Sly1-20-pα21 240 compound mutant were similar. Hence, the amphipathic character of helix α21 is required for the loop's positive functions: activation and normal function of wild type Sly1, as well as hyperactivity of Sly1-20, both in vivo and in vitro.
To further test the hypothesis that the regulatory loop has a positive function we prepared chimeras, with fragments of the loop appended to the amino terminus of the 245 Sly1∆loop mutant ( Fig. 7A; Supplementary Table 3 ). In vivo, chimeras bearing the entire loop, or α20-21, or α21 alone, restored normal growth to Sly1∆loop (Fig. 7B) . Mutation of five hydrophobic residues within α21 eliminated rescue by loop-SLY1∆loop or by α20-21-SLY1∆loop. However, at 30°C the polar mutant pα21-SLY1∆loop grew almost as well as α21-SLY1∆loop. The mechanism of rescue by this mutant construct is unclear.
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In vitro the α20-21-Sly1∆loop chimera drove almost wild-type fusion when added at 800 nM, whereas its polar mutant (α20-pα21-Sly1∆loop) phenocopied Sly1∆loop. Moreover, in contrast to the result obtained in vivo, α21-Sly1∆loop exhibited gain of function relative to Sly1∆loop, while its polar mutant pα21-Sly1∆loop eliminated its gain-of-function relative to Sly1∆loop. Overall (with the interesting exception of the pα21-SLY1∆loop allele's in vivo 255 phenotype), these results indicate that that the evolutionarily conserved portion of the Sly1 loop can partially replace the loop's positive function, even when appended to Sly1 at a nonnative location. A. Chimeric constructs were prepared with different fragments of the Sly1 loop appended to the Nterminus of Sly1 via a short, flexible linker (see Supplementary Table 3 for details). Mutants designated pα21 had the five polar substitutions in the appended loop, as described in Fig. 6c . B. The loop-Sly1 mutants were expressed from the native SLY1 promoter on single-copy plasmids. Growth of a sly1∆ strain was assessed in the presence of the indicated constructs following ejection of a SLY1 balancer plasmid by plating on media containing 5-FOA. C-F. Fusion driven by mutants with fragments of the loop (C,E) or polar derivatives of these fragments (D,F). Points show mean ±s.e.m. of three independent experiments; in many cases the error bars are smaller than the symbols. Gray lines show least-squares nonlinear fits of a second-order kinetic model.
Helix α21 can bind lipid bilayers directly, with preference for high curvature
The above data suggest, but don't prove, that Sly1 helix α21 binds to membranes, and that the loop allows Sly1 to tether vesicles. To test whether α21 binds to membranes we used a FRET assay. A peptide was synthesized comprising α21 and flanking residues, with an N-265 terminal tetramethylrhodamine fluorophore (TMR-α21). A control peptide, TMR-pα21, contained the same five substitutions as the Sly1-pα21 mutant (see Fig. 6A ). Small unilamellar vesicles (SUVs) were prepared with 0.8% Texas Red-phosphatidylethanolamine (TRPE) to serve as a FRET acceptor for TMR. Representative emission spectra for the peptides and SUVs are shown in Fig. 8A . SUVs were prepared in two nominal diameters (30 and 200 nm), and with 270 either 6.7% or 30% ergosterol. When mixed with TRPE-doped SUVs, the α21-TMR peptide generated a reproducible FRET signal, evident mainly as donor quenching (Fig. 8B,C) . Under the same conditions, the control TMR-pα21 peptide exhibited smaller FRET signals. Moreover, the TMR-α21 peptide yielded a larger FRET signal with smaller SUVs, in both the 6.7% and 30% ergosterol conditions (Fig. 8C) . In contrast, the TMR-pα21 FRET signals did not depend on the 275 SUV diameter. We conclude that helix α21 binds directly to membranes through a mechanism involving the apolar residues within α21, and that it prefers to bind membranes with higher curvature. This is reminiscent of the behavior of ALPS domains, proposed to operate as Fig. 8 . Sly1 helix α21 binds membranes, with a preference for higher curvature. TMR-α21 and TMR-pα21 peptides were added to SUVs of nominal diameter 30 and 200 nm, which contained 1% TRPE as a fluorescence acceptor. A. Emission spectra of peptides or liposomes (30 nm diameter, 6.7% ergosterol) measured separately, and the sums of the peptide and liposome spectra. The sums represent the no-FRET condition. Both the TMR-α21 and TMR-pα21 spectra are plotted; they overlap almost exactly. Vertical dashed lines at 585 nm and 610 nm indicate emission peaks for labeled peptides and SUVs, respectively. B. Example of FRET data. Spectra from binding reactions containing SUVs (30 nm diameter, 6.7% ergosterol, 500 µM total lipid) and 25 µM TMR-α21 or TMR-pα21 are shown. The no-FRET condition is shown for reference. C. Normalized FRET ratios for binding reactions containing the indicated combinations of SUVs and peptides, as in panel B. Traces and bars in A-C show means and ±95% confidence bands from 4 independent experiments. membrane selectivity filters in the early secretory pathway. However, helix α21 and the Sly1 loop have a higher fraction of charged residues, and the apolar side chains are less bulky, than 280 in canonical ALPS domains (Drin and Antonny, 2010). These differences may explain the apparent insensitivity of TMR-α21 binding to sterol concentration.
Hyperactive Sly1* directly tethers vesicles to the Qa-SNARE
Sly1 binds to the N-peptide-Habc domain of Sed5 (residues 1-210) with sub-nM affinity 285 (Demircioglu et al., 2014; Grabowski and Gallwitz, 1997; Yamaguchi et al., 2002) . Thus, we hypothesized that Sly1 may tether heterotypically, with one side of Sly1 binding to the Npeptide of Sed5 on the target membrane while the other side, via helix α21, binds directly to the membrane of the R-SNARE-bearing vesicle. To test this hypothesis we adapted a beadbased assay (Fig. 9A ) previously used to study Rab-mediated tethering (Lo et al., 2012) . First,
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GST-Sed5 cytoplasmic domain (GST-Sed5cyt) or control GST protein were adsorbed to glutathione-agarose beads. Then Sly1* wild type or mutant proteins were added and allowed to bind to the immobilized GST-Sed5cyt. Finally, fluorescent vesicles or RPLs were added to the beads, incubated, and imaged by confocal microscopy. If Sly1 or its mutants mediate tethering between Sed5 and the membranes, the signal will be visible in confocal microscopy 295 sections as an equatorial ring of fluorescence on the beads. Qualitative results with wild-type and mutant forms of Sly1 are shown in Fig. 9A . To quantify this tethering a bead spin-down assay was used ( Fig. 9B-D) . When Sly1-20, Sly1-T559I, or Sly1-D563G was added to the beads, robust tethering of SNARE-free small unilamellar vesicles (SUVs) was observed ( Figs. 9A,B) .
Tethering was eliminated if either Sly1 or Sed5 ("GST control") was omitted. Tethering was 300 dramatically attenuated with wild type Sly1, with Sly1∆loop, or with Sly1-pα21. An intermediate tethering signal was observed with Sly1-20-pα21. The partial tethering observed with this compound mutant might be due to eight hydrophobic residues on the loop that are still present in the Sly1-pα21 and Sly1-20-pα21 mutants (see Fig. 6C ). Robust tethering therefore requires that the loop be present, that the loop be open, and that helix α21 be 305 amphipathic. Moeover, as in the peptide binding assays, Sly1-20 mediated tethering was most efficient with small-diameter vesicles, and was insensitive to sterol concentration (compare Figs. 8C and 9C). Together these findings indicate that both helix α21 in isolation, and the Sly1 loop in the context of Sly1-20, sense membrane curvature.
Fig. 9. Hyperactive forms of Sly1 directly tether high-curvature vesicles to immobilized Sed5. A,
The ability of Sed5-bound Sly1 to directly tether vesicles was tested using a bead-based assay system. GST-Sed5 was adsorbed to glutathione-Sepharose (GSH) beads, and wild-type or mutant forms of Sly1 were added to the reaction mixture. After 5 min, fluorescent R-SNARE RPLs bearing Sec22 were added to the mixtures, incubated for 15-20 min, and imaged by confocal microscopy (10× objective). A false-color scale was used to emphasize small differences in contrast under conditions with less tethering. The micrographs are representative of at least two independent assays per condition. B-D, To quantify tethering efficiency we used a spin-down assay. Binding reactions set up as for microscopy were subjected to low-speed centrifugation to sediment the glutathione-Sepharose (GSH beads) and associated proteins and vesicles. The supernatant was removed and detergent was added to the pellet to liberate bound fluorescent lipids; the resulting signal was quantified by fluorometry. In C, Sly1-20 was present for each condition. In D, Sly1* was preincubated with a 6:1 excess of soluble Sed5-Habc or Sed5-N-Habc, as indicated. Y-axes show beadassociated fluorescence (au, arbitrary units) after subtracting background from blanks containing only buffer. Bars indicate means ±95% confidence intervals for 4-10 independent experiments. Sly1 binds the Sed5 N-terminal domain with sub-nM affinity (aa 1-21; Bracher and 310 Weissenhorn, 2002; Demircioglu et al., 2014; Yamaguchi et al., 2002) . To test the importance of this binding interaction in tethering, Sly1-20 was pre-incubated with a 6:1 molar excess of Sed5-N-Habc (aa 1-210; Fig. 9D ). This abolished tethering. In contrast, tethering was not blocked by , which lacks the N-peptide. Thus, to tether vesicles Sly1 must bind the N-peptide of the immobilized Qa-SNARE. Taken together the present and 315 previously reported genetic data, and our assays of in vitro fusion, peptide binding, and tethering, all support the conclusion that the amphipathic helix α21 is necessary and sufficient for direct Sly1 binding to the incoming vesicle's lipid bilayer. This binding both derepresses Sly1 and allows it to tether incoming vesicles at close range.
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DISCUSSION
SLY1 was identified through isolation of the SLY1-20 as a dominant single-copy suppressor of deficiency in YPT1, which encodes the yeast Rab1 ortholog. It soon became apparent that Ypt1 regulates ER-Golgi transport, and that SLY1 gain-of-function alleles might become hyperactive 325 through the loss of negative regulation. The present experiments strongly support that hypothesis, but further demonstrate that helix α21 has at least two functions. First, α21 is needed for relief of Sly1 autoinhibition. Second, α21 has a positive function. Both α21 functions are essential for bypass of tethering requirements by SLY1-20, and both require the presence of conserved apolar residues within α21. The same apolar residues are required for In a working model (Fig. 10A) there is evidence that the hinges cause the tether to buckle or collapse, allowing the vesicle to approach the target membrane (Cheung et al., 2015; Murray et al., 2016) . We propose that in the early secretory pathway long-range tethering factors hand vesicles off to Sly1, which would tether vesicles at a range of ~15 nm from the target membrane to promote trans-SNARE 345 complex assembly (Fig. 10B) . The Sly1 loop's preference for small-diameter vesicles in our binding and tethering assays is reminiscent of the behavior of ALPS domains, which seem to operate as selectivity filters that recognize bulk physical properties of membranes in the early secretory pathway (Bigay et al., 2005; Bigay and Antonny, 2012; Drin et al., 2008; Magdeleine et al., 2016) . We propose that Sly1's tethering function adds an additional layer of selectivity to 350 this system.
In the anterograde ER-Golgi pathway both Sly1 and the Qa-SNARE Sed5 must be present on the Golgi acceptor membrane; they cannot fulfill their functions if located only on COPII-derived transport vesicles (Cao and Barlowe, 2000) . Sly1 is anchored to Sed5 through a direct, sub-nanomolar interaction with the Sed5 N-terminal domain (Bracher and 355 Weissenhorn, 2002; Demircioglu et al., 2014; Yamaguchi et al., 2002) . As our experiments show, Sly1 binding to the Sed5 N-peptide is indispensible for Sly1-mediated tethering (Fig. 10B) .
However, a previous report argued that the Sed5-Sly1 interaction is of relatively minor importance (Peng and Gallwitz, 2004) . In the companion manuscript (Duan et al., submitted) we show, consistent with tethering experiments presented here, that deletion of the Sed5 N-360 peptide severely impairs fusion in vitro and is lethal in vivo.
Sitting almost exactly opposite Sly1's N-peptide-binding cleft is the Sly1 loop (Fig. 10B) .
The loop is mobile: in the Sly1 crystal structure the poorly conserved N-terminal half of the loop is unresolved, while the better-conserved C-terminal half of the loop is partially resolved but exhibits a high temperature (B) factor (Fig. 10C) , an indication of conformational heterogeneity. 365 We speculate that when Sly1 is in its auto-inhibited ground state, helix α21 undergoes a "logrolling" rotation about its long axis, intermittently exposing apolar side chains to probe for the presence of incoming vesicle membranes. Helix α21 binding to the vesicle bilayer has two consequences. First, the loop is pulled open, exposing the R-SNARE binding surface on Sly1.
Second, the loop operates as a close-range tether, stabilizing the vesicle and target 370 membrane within a distance sufficient to allow R-SNARE binding to Sly1 and the nucleation of a trans-SNARE complex on Sly1 domain 3a. The Sly1 loop might also constrain the rotational motion of Sly1 so that Sly1 is optimally oriented for productive R-SNARE binding. Although the available data are entirely consistent with this working model, we emphasize that many details are provisional and should be tested in future studies.
In our in vitro tethering assays, Sly1-20 and other gain-of-function mutants allow efficient tethering, consistent with the ability of these mutants to suppress requirements for other tethering factors. In the same in vitro assays, however, wild type Sly1 tethers much less efficiently. This raises the question of whether close-range tethering is important for wild type Sly1. The Sly1∆loop mutant cannot be auto-inhibited, yet it exhibits substantial tethering and 380 fusion defects in vitro. In vivo, our SGA analyses revealed that the sly1∆loop allele exhibits synthetic sick or lethal interactions with dozens of genes involved in ER and Golgi traffic, including many genes that encode tethering factors or their regulators. In other words, when close-range tethering is prevented even partial defects in long-range tethering result in catastrophe and death. We suggest that a key function of Golgi long-range tethers is to allow 20), the loop may be intrinsically disordered, generating a "steric cushion" that locally exerts force on the adjacent docked membranes (Busch et al., 2015; D'Agostino et al., 2017) . Our evidence for such a steric cushion mechanism is equivocal. In vitro, the behavior of Sly1∆loop, which completely lacks the loop, and of Sly1-20-pα20, which has a full-length loop that is constitutively open but partially defective in 395 membrane binding, exhibit similar defects in most assays. This would argue against the steric cushion hypothesis. In vivo, however, SLY1-20-pα20 allows almost wild type growth, while the sly1∆loop mutant grows slowly. Finally, it is possible that α21 binding to the vesicle locally perturbs its membrane structure, lowering the energy barrier for the onset of lipid mixing.
Additional work will be needed to evaluate these potential mechanisms. Kosodo et al., 1998) . (ii) As we have shown here, helix α21 binding to membranes both de-represses and directly promotes Sly1 activity through a mechanism involving close-range vesicle tethering. (iii) Sly1 has conserved structural features that in Munc18-1 and Vps33 have been shown to catalyze trans-SNARE complex assembly through a Qa-R-SNARE templating mechanism. (iv) We have shown (again in aqueous solution but corroborated by genetic experiments) that Sly1 can decrease the rate of SNARE complex disassembly by Sec17 and Sec18. In the accompanying manuscript (Duan et al., submitted) we 410 argue that that each of these mechanisms contributes to Sly1 function and that all are required for full Sly1 activity. In particular, we show that the close-range tethering mechanism characterized here is central Sly1's ability to selectively nucleate trans-versus cis-SNARE complexes.
The Sly1 loop is conserved among Sly1 homologs from yeast to human but is absent 415 from representatives of the three other SM sub-families: Sec1/Munc18, Vps45, and Vps33. Why is the loop unique to Sly1? We suggest that Sly1 must function in a considerably broader variety of cellular and molecular contexts than other SM's. For example, the endosomal SM Vps45 associates with a scaffold protein, Vac1 (in mammals, Rabenosyn-5). Vac1 binds both Rab5 and phosphatidylinositol-3-phosphate, and might mediate close-range tethering in a 420 manner analogous to the Sly1 loop (Burd et al., 1997; Peterson et al., 1999; Rahajeng et al., 2010; Tall et al., 1999) . Similarly, Sec1 physically and functionally interacts with the exocyst tethering complex, and Vps33 is stably associated with Vps-C tethering complexes including HOPS and CORVET, which subsume both tethering and SNARE assembly functions (Morgera et al., 2012; Rieder and Emr, 1997) . In the case of exocyst, the tethering activity is subject to 425 autoinhibition, which is apparently released by engagement of rho family GTPases (Rossi et al., 2020) .
In an interesting parallel, an ALPS-like domain within the HOPS subunit Vps41 was proposed to select high-curvature endocytic vesicles for docking and fusion (Cabrera et al., 2010) . We also note that Munc18-1, despite lacking the Sly1-specific regulatory loop, is 430 reported to tether vesicles in a reaction that requires at least the Qa-SNARE N-peptide and the R-SNARE on the opposing membrane (Arnold et al., 2017; Tareste et al., 2008) . It is not clear whether Munc18-1 mediated tethering entails a direct interaction between Munc18-1 and the vesicle bilayer. This parallel may suggest that close-range tethering is a subreaction common to SM function.
Which specific long-range tethers hand vesicles off to Sly1 for close-range tethering, docking, and fusion? Persuasive experiments show that Sly1 operates in concert with Ypt1 and Uso1 (yeast Rab1 and p115, respectively) on the anterograde ER-Golgi pathway (Cao and Barlowe, 2000) . However, direct interactions between Sly1 and Ypt1 or Uso1 have not been detected. Binding interactions have been detected between human Sly1 and COG, and 440 perhaps between yeast Sly1 and Dsl (Kraynack et al., 2005; Laufman et al., 2009 ). However, the positive suppressing interactions of SLY1-20, the negative synthetic sick or lethal interactions of sly1∆loop, and the known SNARE interactions of Sly1, all point to Sly1 operating as "receiving agent" for vesicular traffic into the ER, early Golgi compartments, and perhaps later Golgi compartments as well. Additionally, several ER and Golgi tethers are reported to bind 445 directly to Sly1 client SNAREs. Thus Sly1 might accept cargo containers presented by COG, GARP, TRAPP, Dsl, and the various Golgins. A significant challenge for the future is to identify the combinations of long-range tethers and SNAREs that operate in concert with Sly1, and to delineate the mechanisms that coordinate handoffs from long-range tethers to the core fusion machinery.
MATERIALS & METHODS
Yeast strains and SLY1 gain-of-function screen. We use standard Saccharomyces genetic nomenclature (Dunham et al., 2015) . Dominant alleles, whether wild type or mutant, are 455 named in uppercase type (e.g., ; recessive alleles are named in lowercase (e.g., sly1∆loop). Strains and plasmids used in this study are described in Supplementary Table 4 .
To obtain new suppressors of uso1∆, a library of SLY1* mutant alleles was constructed using the GeneMorph II Random Mutagenesis Kit (Agilent #200550). The SLY1 open reading frame was amplified using the "medium mutation rate" PCR protocol. Four mutagenic PCR pools 460 were separately purified and cloned into a derivative of the yeast vector pRS415, which contained 431 bp of the SLY1 promoter and 249 bp of the SLY1 terminator, using traditional restriction-ligation methods. Aliquots of the pRS415::SLY1 mutant library ligation products were transformed into TOP10F´chemically competent E. coli cells, and 10 individual clones were Sanger sequenced to assess cloning fidelity and mutation frequency. Each clone 465 sequenced contained the SLY1 open reading frame with 0-4 mutations, with about 50% of the clones containing mutations. After the SLY1 mutant library pools were verified, aliquots of the mutant library ligation products were transformed into Bioline Alpha-Select Gold Efficiency Competent E. coli cells. Transformant colonies were scraped from the LB + Amp transformation plates (maintaining four separate mutant pools), and allowed to grow for 470 about two doublings. Plasmid DNA was extracted and purified from each of the pooled cultures using Qiaquick columns. 1ug of plasmid DNA from each SLY1 mutagenic pool was transformed into S. cerevisiae strain AMY2144 (CBY1297: uso1∆ pRS426::USO1). Transformant colonies were grown under selection for leucine auxotrophy, then replica plated to synthetic complete medium containing 5-FOA, and incubated for 2 days. Yeast colonies that grew on 5-475 FOA (thus "kicking out" the WT copy of USO1) where struck out on -LEU plates, and plasmid DNA was purified from ten or more clones from each pooled library, using the Smash and Grab procedure. Plasmids were Sanger sequenced. On the basis of these results, pRS415::SLY1 single mutant alleles were constructed. Site-directed SLY1* mutants were constructed using PCR and Gibson assembly, and are described in Supplementary Tables 1-3 . The second half 480 of sly1-pα21 gene and its derivative SLY1-20-pα21 (see Supplementary Table 2 ) were ordered as a gBlock (IDT) and cloned into the BamHI and NcoI sites on the wild-type SLY1 plasmid.
SGA analysis.
A query strain (AMY2443) was constructed in the Y9205 genetic background (Tong and Boone, 2005) , with sly1∆loop and a linked nourseothricin (NAT) marker integrated 485 through allelic replacement at the native SLY1 locus. This query strain was crossed to the MAT a haploid deletion and DAmP libraries, where each individual genetic perturbation is marked with a KAN resistance marker (Breslow et al., 2008; Tong and Boone, 2005) . Diploids were selected by robotic pinning (Singer RoToR) onto YPD + 100 mg/L clonNAT + 200 mg/L G418, then induced to sporulate by pinning to sporulation medium (20g/L agar, 10g/L potassium 490 acetate, 1g/L yeast extract, 0.5g/L glucose, 0.1g/L amino acid supplement [2g histidine, 10g leucine, 2g lysine, 2g uracil]) and growth at room temperature for 5 days. Spores were subsequently pinned to haploid selection medium (SD -His/Arg/Lys + 50 mg/L canavanine + 50 mg/L thialysine) and MAT a meiotic progeny grown for 2 days at 25º C. This haploid selection step was repeated, and the resulting colonies imaged using a Phenobooth (Singer) imaging 495 system. These colonies encompass all potential meiotic progeny and serve as the control strains for phenotypic normalization. Haploid double mutants carrying both the KAN deletion allele and the sly1∆loop::NAT allele were selected by pinning meiotic progeny to double selection medium (SD/MSG -His/Arg/Lys + 50mg/L canavanine + 50 mg/L thialysine +100 mg/L clonNAT + 200 mg/L G418). After 2 days of growth at 25º C, this selection step was repeated 500 and duplicate plates incubated at either 30º C or 37º C. Plates were imaged using the Phenobooth system, and colony size differences calculated using PhenoSuite software and web app (https://singerinstruments.shinyapps.io/phenobooth/).
Protein purification.
Full-length SNARE proteins were produced as previously described (Furukawa and Mima, 2014) with modifications. E. coli Rosetta2 (DE3) pLysS cells (Novagen) 505 harboring each of the SNARE expression plasmids with 3C protease-cleavable N-terminal tags (pET-41/GST-His6 for SEC22 and pET-30/His6 for SED5, BOS1 and BET1) were inoculated from a 1:1000 dilution of the starter culture grown in MDAG-135 medium (Studier, 2005) into 1 L of Terrific Broth supplemented with 100 µg/mL Kanamycin and 34 µg/mL Chloramphenicol and grown at 37°C, 275 rpm until OD600 reached ~1. Cultures were then induced with 1 mM IPTG 510 for 3 h at 37°C. Cultures were harvested at 5000 × g and cell pellets were snap frozen with liquid nitrogen. Each liter yielded ~10 g of wet cells, which were stored at −70°C. For purification, the frozen pellets were warmed to −10° C and broken up into small pieces with a metal spatula, then resuspended at a ratio of 5 mL of buffer per g of cell paste in 1× SNARE buffer (20 mM Na·PO4, 500 mM NaCl, 10% (m/v) glycerol, 1 mM DTT, pH 7) supplemented with 515 30-40 mM imidazole, 0.25 mg/mL chicken egg lysozyme, 125 U benzonase per g of cells, and 1× Sigmafast Protease inhibitor cocktail. 4 mL (1/10 volume) of 1 M n-octyl-β-D-glucopyranoside in H2O (β-OG, Anatrace) was added to 100 mM final concentration; the suspension was rotated at room temperature for 25 min to allow detergent-aided enzymatic lysis. Lysates were clarified at 16,500 × g, 4° C for 10 min, transferred to clean centrifuge tubes and centrifuged 520 again for 20 min. Clarified lysates were batch-bound with 2ml of Ni-Sepharose HP equilibrated in 1× SNARE buffer with β-OG for 30 minutes. SNARE-bound resin was washed in plastic disposable columns with 25 mL of SNARE buffer supplemented with β-OG and 60-100 mM imidazole. SNARE proteins were eluted with SNARE buffer supplemented with β-OG and 200-300 mM imidazole, and snap frozen in liquid nitrogen. Purified protein was quantified using by 525 absorbance at 280 nm and purity was assessed with SDS-PAGE with Coomassie blue staining.
Protein aliquots were stored at −70° C until reconstitution. We note that 3C protease caused substantial unintended cleavage of Bos1 in its N-terminal linker domain due to a cryptic 3C site (148-GLPLYQ/GL-155). Mutation of the poorly-conserved residue Q153 to aspartic acid eliminated unintended proteolysis.
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Soluble domains of Sed5 were expressed from the pET-30 vector (for H6-Habc and H6-N21-Habc) or pET-49 vector (for GST-H6-SED5∆TM) and purified in same way as the full length protein except that the temperature was lowered to 35°C prior to induction, the buffers did not contain β-OG, and lysis was performed using Emulsiflex-C5 high pressure homogenizer (Avestin). Eluted protein was exchanged into FB160M1 (20 mM HEPES·KOH, 160 mM KOAc, 535 10% (m/v) Glycerol, 1mM MgOAc2, pH 7) using a PD-10 desalting column. Precipitated material was removed by centrifugation at 10,000 × g for 10 minutes and soluble protein aliquots were snap frozen in liquid nitrogen in 250ul PCR tubes and stored at −80° C. Sec22(SNARE)-GFP-His8 was expressed from the pST50Trc1 vector in Rosetta2(DE3) cells grown in ZYM-5052 autoinduction media (Studier, 2005) supplemented with carbenicillin (100 µg/mL) and 540 chloramphenicol (34 µg/mL) overnight (>16 h) at 30° C from a 1:1000 dilution of starter culture.
Cells were harvested and protein was purified as for soluble domains of Sed5. Sec17 was purified as described (Schwartz and Merz, 2009 ) except that the culture was grown in ZYM-5052 autoinduction media (Studier, 2005) at 37°C until OD600nm was ~0.8; temperature was then lowered to 18°C and the culture was incubated for ~24 hours. Sec18 was purified as described 545 (Haas and Wickner, 1996) .
Sly1 and its mutants were expressed in Rosetta2(DE3) cells from pHIS-Parallel1 vectors (Lobingier et al., 2014; Sheffield et al., 1999) . Frozen glycerol stocks were used to inoculate overnight starter cultures at 37° C in MDAG-135 containing 100 mg/L carbenicillin and 50 mg/L chloramphenicol (Studier, 2005) . Each starter culture was diluted 1/1000 to seed B88 buffer, used extensively in COPII vesicle budding assays (Baker et al., 1988) , and from lipidomic studies. The ER lipid mix is based on "Major-Minor" mixtures used for COPII budding (Antonny et al., 2001; Matsuoka et al., 1998) , while the Golgi-mix is based on lipidomic surveys (Klemm et al., 2009; Schneiter et al., 1999) . In particular, the study of Schneiter et al. used a highly enriched Golgi fraction known to be competent for docking and fusion of COPII carrier 605 vesicles . Relatively high concentrations of ergosterol were used based prior work on COPII budding, which demonstrated that higher sterol levels yielded more morphologically homogenous COPII budding profiles (Matsuoka et al., 1998) . In pilot studies, however, RPLs prepared with lower ergosterol concentrations exhibited similar fusion characteristics, including Sly1 and PEG dependence, as the high-sterol RPLs used in the 610 experiments presented here. Lipids were obtained from Avanti Polar Lipids as chloroform stocks (Alabaster, AL) except for ergosterol, which was from Sigma-Aldrich. Supplementary   Table S5 lists the proportions, working stocks, and volumes of lipids and detergent used to prepare ER-mix and Golgi-mix RPLs. Lipid stocks were prepared or purchased in chloroform, except for ergosterol and phosphatidylinositol-4-phosphate, which were dissolved in 1:1 615 chloroform:methanol. β-OG stock solutions were prepared in methanol. Lipid-detergent films were prepared by transferring lipid and β-OG stocks to a glass vial (typically, 8 µmol total lipids and 70 µmol β-OG). The mixture was dried under a nitrogen stream; residual solvent was removed using a Speedvac™ evaporator. The lipid-detergent film was hydrated and solubilized with 400 µL 5× FB160M1 by three cycles of bath sonication and shaking. To the lipid-620 β-OG mixture, content mixing FRET reporters were then added (500 µL of 4 mg/mL solution of R-phycoerythrin-biotin conjugate, or 296 µL of 2mg/mL Alexa-Streptavidin; both reagents from Thermo/Molecular Probes). SNARE stocks in SNARE elution buffer with β-OG were then added to a final molar ratio of 1:600 (each Q-SNARE) or 1:300 (Sec22) to total phospholipids. Water was used to fill the headspace necessary to dilute 5× FB160M1 buffer to 1× concentration (2 mL 625 final volume). Mixtures were nutated for 30 minutes before recombinant 3C protease was added (in 1:10 ratio to total SNAREs) to cleave affinity tags from the SNARE proteins during dialysis. The resulting mixtures were dialyzed (20 kDa cutoff) for ~18h at 4°C in the dark against 250 volumes of FB160M1 containing 2 g BioBeads SM2 (Bio-Rad, Hercules, CA) per 2 mL of RPL mixture. The RPL mixture was then separated from unencapsulated content mixing probe by 630 floating the RPLs up a step gradient of iso-osmotic Histodenz (35/25/0%) in FB160M1 (SW60Ti rotor at 55k rpm for 90 min), harvested, and diluted to 2 mM phospholipid. Phospholipid was quantified by measuring the fluorescence of the membrane fluorophore, initially verified by inorganic phosphate analysis (Chen et al., 1956) . 32 µL aliquots of RPLs were transferred to thinwall PCR tubes and frozen by immersion in liquid N2. RPLs prepared by this method and stored 635 at −80° C were stable and fusion-competent, with minimal leakage of encapsulated FRET probes, for at least one year. RPL fusion assays. Unless noted otherwise, a standard order-of-addition was always used to initiate RPL assays. 250 µM (final phospholipid) of each RPL was premixed with PEG6K and other fusion components such as Sec17, Sec18 and ATP. Fusion assays were performed in 20 640 µL sample volumes in 384-well plates (Corning #4514). The reactions were monitored in a plate-based fluorimeter (Molecular Devices Gemini XPS or EM) for 5 min to establish a baseline, then Sly1 was added to initiate fusion. Except as noted, the moment of Sly1 addition was defined as time = 0. Lipid mixing was monitored with Ex370nm and Em465nm. Content mixing was monitored with Ex565nm and Em670nm. Graphs show mean ± s.e.m. of n ≥ 3 independent 645 assays. Curves on the graphs show a second-order kinetic model fit to each dataset using a weighted least-squares algorithm in GraphPad Prism. Some experiments were run in both the presence and absence of unlabeled streptavidin, to assess leakage of RPL aqueous contents.
For content mixing, typical signal for a complete reaction over background (e.g., no Sly1) exceeded 50:1.
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Yeast growth assays. Yeast strains containing pRS426::USO1 or pRS416::YPT1 and pRS415::SLY1 mutant plasmids were grown in -LEU liquid media, then diluted using a 48-pin manifold or a multichannel pipettor onto 5-FOA plates. The 5-FOA plates were grown at restrictive or non-restrictive temperatures, as indicated. Growth was scored relative to positive and negative control strains after 2-3 days. this mixture was incubated, with slow agitation, for 30 min at room temperature. Unbound material was removed by gentle centrifugation (~70 × g, 10 seconds), the beads were washed 675 once with FB160BSA, and the beads were then blocked by adding excess recombinant GST-His6 protein (1.25 mg; 2.5 × the resin's nominal binding capacity) in FB160BSA, in 500ul final volume. Unbound GST-H6 was not removed. The bead-SED5-GST suspension was stored at 4° for up to a week. For tethering assays, 1× reaction aliquots of the bead-SED5-GST suspension (50 µL, containing ~10 µL packed beads) were transferred to 250 µL PCR tubes, then Sly1* (75 680 pmol; a 1:2 molar ratio to Sed5cyt) was added to each reaction tube in 50 µL volume, allowing the Sly1* to bind to the immobilized GST-Sed5cyt in 100 µL final volume. For competition experiments the Sly1* was pre-incubated with a 6-fold molar excess (450 pmol) of Sed5 Habc or N-Habc domain for 10 min at room temperature before adding the Sly1*-competitor mixture to the beads. Tethering was initiated by adding Texas-red-DHPE labeled SUVs to each 685 1× tethering reaction (1-6 µL depending on stock concentration). The tethering reactions were incubated for 15-20 min at room temperature, then transferred to wells of chambered coverslips that had been pre-incubated with FB160BSA for at least 20 min. These preparations were observed at ambient temperature (23±2° C) using a Nikon Ti2 microscope equipped with a Yokogawa CSU-X1 spinning disk confocal unit, a Toptica iChrome MLE laser combiner and 690 launch; 405, 488, 561, and 647 nm diode lasers (Coherent); a Finger Lakes high-speed emission filter wheel; and a Mad City piezoelectric Z-stage. The microscope was controlled by Nikon Elements software and data analysis and figure preparation was done with the Fiji package of Image/J software and plug-ins. Tethering reactions were observed using a 10× 0.30 NA Plan Fluor objective and an Andor 888 EMCCD camera operated at an EM gain of 300 with 200 ms 695 exposure per frame.
Tethering was also quantified using bead spin-down assays. Binding reactions were initiated as in the microscopy-based tethering experiments. To quantify SUVs tethered to the beads, the beads were washed once in 1.3 mL of FB160BSA and then sedimented for 1 min at 500 × g in a swinging-bucket rotor. The supernatant was carefully removed, and resin-bound lipids 700 were eluted from the beads with 50 µL of BugBuster protein extraction reagent (Millipore). The beads were again sedimented. To quantify the amount of eluted TRPE lipid, 20 µL of the final supernatant was analyzed in a plate-reading fluorimeter (Molecular Devices Gemini XPS or Gemini EM; excitation 595 nm; cutoff 610 nm; emission 615 nm). 
